Differential/JJ
contribution/NN
of/IN
herpes/NN
simplex/NN
virus/NN
type/NN
1/CD
gene/NN
products/NNS
and/CC
cellular/JJ
factors/NNS
to/TO
the/DT
activation/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
provirus/NN
./.

We/PRP
have/VBP
previously/RB
reported/VBN
that/IN
infection/NN
with/IN
herpes/NN
simplex/NN
virus/NN
type/NN
1/CD
(/(
HSV-1/NN
)/)
activates/VBZ
expression/NN
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
(/(
HIV-1/NN
)/)
provirus/NN
in/IN
T/NN
cells/NNS
./.
=====
Activation/NN
of/IN
the/DT
HIV-1/NN
provirus/NN
correlated/VBD
with/IN
the/DT
activation/NN
of/IN
binding/NN
of/IN
55-/CD
and/CC
85-kDa/JJ
proteins/NNS
to/TO
the/DT
kappa/NN
B/NN
enhancer/NN
and/CC
binding/NN
of/IN
the/DT
50-kDa/JJ
HLP-1/NN
protein/NN
to/TO
the/DT
LBP-1/NN
sequences/NNS
of/IN
the/DT
HIV-1/NN
long/JJ
terminal/JJ
repeat/NN
./.
=====
Further/RB
examination/NN
of/IN
this/DT
system/NN
has/VBZ
shown/VBN
that/IN
the/DT
inhibition/NN
of/IN
HSV-1/NN
replication/NN
by/IN
the/DT
antiviral/JJ
drug/NN
acyclovir/NN
does/VBZ
not/RB
inhibit/VB
HSV-1-mediated/JJ
induction/NN
of/IN
HIV-1/NN
provirus/NN
./.
=====
Surprisingly/RB
,/,
the/DT
NF-kappa/NN
B/NN
and/CC
HLP-1/NN
binding/NN
activities/NNS
were/VBD
substantially/RB
inhibited/VBN
in/IN
acyclovir-treated/JJ
cells/NNS
./.
=====
In/IN
the/DT
transient-transfection/JJ
assay/NN
,/,
ICP0/NN
,/,
but/CC
not/RB
ICP4/NN
,/,
activated/VBD
the/DT
HIV-1/NN
long/JJ
terminal/JJ
repeat/NN
promoter/NN
region/NN
and/CC
the/DT
effect/NN
of/IN
ICP0/NN
was/VBD
greatly/RB
enhanced/VBN
in/IN
the/DT
presence/NN
of/IN
the/DT
NF-kappa/NN
B/NN
binding/NN
proteins/NNS
,/,
suggesting/VBG
that/IN
induction/NN
of/IN
the/DT
HIV-1/NN
provirus/NN
involves/VBZ
cooperation/NN
between/IN
the/DT
HSV-1-activated/JJ
cellular/JJ
factor/NN
,/,
NF-kappa/NN
B/NN
,/,
and/CC
the/DT
virus-encoded/JJ
transactivator/NN
,/,
ICP0/NN
./.